Curaleaf Holdings Debt to Equity Ratio 2019-2025 | CURLF

Current and historical debt to equity ratio values for Curaleaf Holdings (CURLF) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Curaleaf Holdings debt/equity for the three months ending March 31, 2025 was 1.08.
Curaleaf Holdings Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2025-03-31 $2.13B $0.81B 2.62
2024-12-31 $2.09B $0.86B 2.43
2024-09-30 $2.12B $0.96B 2.21
2024-06-30 $2.09B $0.99B 2.11
2024-03-31 $1.95B $1.14B 1.72
2023-12-31 $1.93B $1.17B 1.64
2023-09-30 $2.01B $1.21B 1.66
2023-06-30 $2.12B $1.18B 1.80
2023-03-31 $2.13B $1.23B 1.73
2022-12-31 $2.14B $1.28B 1.67
2022-09-30 $1.97B $1.43B 1.38
2022-06-30 $1.87B $1.49B 1.25
2022-03-31 $1.89B $1.52B 1.25
2021-12-31 $1.56B $1.55B 1.01
2021-09-30 $1.41B $1.76B 0.80
2021-06-30 $1.35B $1.81B 0.75
2021-03-31 $1.08B $1.61B 0.67
2020-12-31 $0.99B $1.38B 0.71
2020-09-30 $0.97B $1.39B 0.70
2020-06-30 $0.00B $0.00B 0.00
2020-03-31 $0.00B $0.00B 0.00
2019-12-31 $0.33B $0.40B 0.83
2019-09-30 $0.00B $0.00B 0.00
2019-06-30 $0.00B 0.00
2019-03-31 $0.00B 0.00
2018-12-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.565B $1.343B
Curaleaf Holdings Inc. operates as a holding company, through its subsidiaries, engages in the production and distribution of cannabis products. Curaleaf Holdings serves dispensary and cultivation sites principally in North America. Curaleaf Holdings Inc. is based in Wakefield, Massachusetts.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $233.364B 28.06
Stryker (SYK) United States $146.969B 30.73
Boston Scientific (BSX) United States $146.968B 36.79
EssilorLuxottica (ESLOY) France $131.277B 0.00
Medtronic (MDT) Ireland $112.813B 15.99
Lonza Group Ag (LZAGY) Switzerland $50.710B 0.00
Haleon (HLN) United Kingdom $49.016B 27.92
ResMed (RMD) United States $37.047B 27.83
Agilent Technologies (A) United States $34.235B 22.32
GE HealthCare Technologies (GEHC) United States $33.847B 16.07
Terumo (TRUMY) Japan $26.946B 35.00
Koninklijke Philips (PHG) Netherlands $22.399B 16.10
Insulet (PODD) United States $21.023B 82.52
Zimmer Biomet Holdings (ZBH) United States $18.780B 12.06
Baxter (BAX) United States $16.278B 12.15
Smith & Nephew SNATS (SNN) United Kingdom $13.165B 0.00
Sunny Optical Technology (SNPTF) China $9.076B 0.00
Demant (WILYY) Denmark $8.854B 0.00
Bio-Rad Laboratories (BIO) United States $6.273B 21.83
Lantheus Holdings (LNTH) United States $5.564B 14.03
Prestige Consumer Healthcare (PBH) United States $4.281B 19.13
Perrigo (PRGO) Ireland $3.794B 9.62
Haemonetics (HAE) United States $3.466B 15.79
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.367B 24.83
Envista Holdings (NVST) United States $3.244B 26.96
GN Store Nord (GNNDY) Denmark $2.180B 18.06
QuidelOrtho (QDEL) United States $2.091B 14.38
LeMaitre Vascular (LMAT) United States $1.890B 42.24
AtriCure (ATRC) United States $1.653B 0.00
Acuren (TIC) United States $1.314B 0.00
Neogen (NEOG) United States $1.268B 16.22
AdaptHealth (AHCO) United States $1.190B 12.08
BioLife Solutions (BLFS) United States $1.136B 0.00
Green Thumb Industries (GTBIF) United States $1.063B 23.91
Kestra Medical Technologies (KMTS) United States $1.053B 0.00
Phibro Animal Health (PAHC) United States $0.987B 12.61
InMode (INMD) Israel $0.920B 9.27
CeriBell (CBLL) United States $0.640B 0.00
Evolus (EOLS) United States $0.636B 0.00
Capricor Therapeutics (CAPR) United States $0.634B 0.00
Owens & Minor (OMI) United States $0.629B 5.22
Maravai LifeSciences Holdings (MRVI) United States $0.550B 0.00
Valneva SE (VALN) France $0.535B 0.00
Tilray Brands (TLRY) Canada $0.422B 0.00
Surmodics (SRDX) United States $0.418B 0.00
VAREX IMAGING (VREX) United States $0.367B 13.50
SNDL (SNDL) Canada $0.347B 0.00
Aurora Cannabis (ACB) Canada $0.334B 59.50
SEMPERIT AG HLD (SEIGY) Austria $0.283B 0.00
Canopy Growth (CGC) Canada $0.276B 0.00
Cerus (CERS) United States $0.275B 0.00
Viemed Healthcare (VMD) United States $0.273B 23.00
ZimVie (ZIMV) United States $0.266B 12.09
Sanara MedTech (SMTI) United States $0.265B 0.00
Sanuwave Health (SNWV) United States $0.264B 0.00
Quanterix (QTRX) United States $0.256B 0.00
Cresco Labs (CRLBF) United States $0.253B 0.00
Omeros (OMER) United States $0.227B 0.00
Biote (BTMD) United States $0.227B 6.37
OraSure Technologies (OSUR) United States $0.224B 0.00
Brainsway (BWAY) Israel $0.216B 57.30
TriSalus Life Sciences (TLSI) United States $0.211B 0.00
Organigram Global (OGI) Canada $0.191B 0.00
High Tide (HITI) Canada $0.188B 0.00
Utah Medical Products (UTMD) United States $0.186B 15.16
Verano Holdings (VRNOF) United States $0.180B 0.00
Exagen (XGN) United States $0.157B 0.00
Vireo Growth (VREOF) United States $0.133B 0.00
FitLife Brands (FTLF) United States $0.131B 16.18
MacroGenics (MGNX) United States $0.112B 0.00
Jin Medical (ZJYL) China $0.105B 0.00
Veru (VERU) United States $0.098B 0.00
Fonar (FONR) United States $0.092B 11.88
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
Quipt Home Medical (QIPT) United States $0.090B 0.00
Agape ATP (ATPC) $0.079B 0.00
TerrAscend (TSNDF) Canada $0.074B 0.00
Apyx Medical (APYX) United States $0.069B 0.00
InterCure (INCR) Israel $0.067B 0.00
Cytosorbents (CTSO) United States $0.066B 0.00
Zynex (ZYXI) United States $0.066B 0.00
Jushi Holdings (JUSHF) United States $0.059B 0.00
ImmuCell (ICCC) United States $0.057B 0.00
Modular Medical (MODD) United States $0.045B 0.00
Nephros (NEPH) United States $0.041B 55.43
United-Guardian (UG) United States $0.037B 12.94
Rockwell Medical (RMTI) United States $0.035B 0.00
Safety Shot (SHOT) United States $0.020B 0.00
Allurion Technologies (ALUR) United States $0.020B 0.00
Cellectar Biosciences (CLRB) United States $0.017B 0.00
Flora Growth (FLGC) United States $0.016B 0.00
INLIF (INLF) $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.008B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.005B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00